Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Study of DIC075V in Acute Post-Operative Pain
NCT00726388Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of diclofenac in postoperative pain, sponsored by Pfizer. Primary endpoints: Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs), Number of Participants Who Took at Least 1 Concomitant Medication and 14 more. Started Sep 2008; status: completed.
02
Drugs
diclofenac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00726388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00726388.